PwC

Opinion: Four reasons Texas Health Aetna joint venture is workingAs the industry moves to a value-based care model, here’s how one North Texas partnership is reinventing healthcare.
Non-physician providers play critical role in optimizing carePwC report finds most primary care teams not designed to optimize care. Here’s how to mobilize non-physicians to create a care dream team.
CMS grants docs reprieve from MACRA implementationHere’s how you can take advantage of this breathing room.
Launching a provider-sponsored health plan: 5 things to knowAs health systems and physician groups marshal resources to launch their own plans, they must consider whether they have the necessary building blocks to successfully make the leap, how integrated a model they will pursue and whether they will build, buy or partner strategy.
How to scale your population health programA new PwC Health Research Institute report notes that while strides are being made in population health, many organizations struggle to scale efforts.
New rheumatoid arthritis therapies are comingFour new drugs and a biosimilar should be on your radar.
RA medications require unique cost considerationsWhen it comes to managing rheumatoid arthritis drugs, cost comes in various sizes and shapes.
Rite Aid buys PBM EnvisionRxIn a move widely seen as a way to better compete with the other major chain drugstores, Rite Aid Corp. has announced an agreement on Feb. 11 to buy the pharmacy benefits manager (PBM) EnvisionRx for about $2 billion.